An International Study to Evaluate Anti-HIV Therapy Plus Interleukin-2 (rIL-2) in HIV Positive Patients - Related Studies

An International Study to Evaluate Anti-HIV Therapy Plus Interleukin-2 (rIL-2) in HIV Positive Patients

This study is ongoing, but not recruiting participants.

Study NCT00004978. Last updated on August 7, 2008. Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		HIV Infections

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Communicable Diseases
		Infection

3	More general conditions related to this trial
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Virus Diseases

4	Interventions listed in this trial
		Aldesleukin

5	Additional drug interventions recognized in this trial
		Interleukin-2

6	More general drug interventions related to this trial
		Analgesics
		Analgesics, Non-Narcotic
		Anti-HIV Agents
		Anti-Infective Agents
		Anti-Retroviral Agents
		Antineoplastic Agents
		Antiviral Agents
		Central Nervous System Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sensory System Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		National Institute of Allergy and Infectious Diseases (NIAID)
		Chiron Corporation